![]() |
市場調查報告書
商品編碼
1492266
自動體外心臟去顫器市場:按類型、最終用戶分類 - 2024-2030 年全球預測Automated External Defibrillator Market by Type (Fully Automatic, Semi-Automatic), End-user (Home Healthcare, Hospitals, Workplaces & Government Facilities) - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年自動體外心臟去顫器市場規模為16.5億美元,預計2024年將達18億美元,2030年將達31.3億美元,複合年成長率為9.59%。
自動體外心臟去顫器(AED) 市場是由全球心血管疾病的增加所推動的,心血管疾病是全球死亡率的主要原因。自動體外心臟去顫器是重要的救生設備,旨在診斷和治療危及生命的心律不整,例如心室顫動和無脈性心室心搏過速。這些設備專為外行人和專業人士使用而設計,並配有語音提示和視覺訊號等引導系統,以便在緊急情況下輕鬆使用。其應用涵蓋各種高風險公共環境,包括機場、學校、體育場、家庭醫療機構和醫院。公眾意識的提高和培訓工作以及強制在公共場所安裝 AED 的立法措施進一步支持了市場擴張。然而,高昂的購置和維修成本以及公眾缺乏培訓等挑戰是更廣泛普及的障礙。儘管存在這些障礙,但在技術進步使設備更易於使用、更有效的推動下,市場前景仍然樂觀。數位整合使技術創新變得越來越可能,例如允許 AED 自動提醒醫療服務或透過 GPS 指導救援人員。此外,正在推動針對環境的AED選項的開發,以降低製造成本並擴大使用場景的範圍。正在進行的關於提高診斷能力和客製化設備的研究代表了一種積極主動的方法,可以克服現有的局限性,提高 AED 的可及性和緊急應變的有效性,並最終提出一條可以挽救許多生命的有希望的軌跡。
主要市場統計 | |
---|---|
基準年[2023] | 16.5億美元 |
預測年份 [2024] | 18億美元 |
預測年份 [2030] | 31.3億美元 |
複合年成長率(%) | 9.59% |
區域洞察
由於促進 AED 培訓和使用的政府政策和公共衛生舉措,美洲地區(尤其是美國和加拿大)對 AED 重要性的認知很高。學校、機場、體育設施等許多公共場所都需要安裝AED。該地區是一個成熟的市場,由於醫療基礎設施完善和鼓勵部署 AED 的嚴格法規,正在穩步成長。 EMEA(歐洲、中東和非洲)地區的 AED 市場複雜但不斷成長。在歐洲,由於嚴格的健康和安全法規以及不斷加強的公眾意識提升宣傳活動,英國、德國和法國等國家具有強大的市場滲透力。由於醫療基礎設施的改善和健康意識的提高,中東顯示出成長潛力。然而,在非洲,由於經濟限制和醫療系統不發達,普及和採用率較低,但隨著意識和基礎設施的改善,市場正在逐漸成長。在亞太地區,由於醫療保健支出增加以及政府改善緊急醫療回應系統的主導,AED 市場正在迅速普及。由於強力的法律規範和公共衛生宣傳活動,日本、澳洲和韓國等國家的普及很高。另一方面,由於都市化的加速、中等收入群體的壯大以及醫療保健意識的提高,中國和印度等新興國家提供了巨大的成長機會。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在自動體外心臟去顫器市場中的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對自動體外心臟去顫器市場中供應商的當前狀態進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對自動體外心臟去顫器市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[196 Pages Report] The Automated External Defibrillator Market size was estimated at USD 1.65 billion in 2023 and expected to reach USD 1.80 billion in 2024, at a CAGR 9.59% to reach USD 3.13 billion by 2030.
The automated external defibrillator (AED) market is witnessing significant growth driven by the global increase in cardiovascular diseases, major contributors to mortality worldwide. Automated External Defibrillators are critical, lifesaving devices engineered to diagnose and treat life-threatening cardiac arrhythmias like ventricular fibrillation and pulseless ventricular tachycardia. These devices are designed for use by both laypersons and professionals, featuring guidance systems such as voice prompts and visual signals to ensure ease of use in emergencies. Their applications span various high-risk public environments, including airports, schools, sports venues, in-home healthcare settings, and hospitals. Market expansion is further supported by heightened public awareness and training initiatives, alongside legislative measures mandating AEDs in public spaces. However, challenges such as high acquisition and maintenance costs and a general lack of public training pose barriers to broader adoption. Despite these hurdles, the market outlook is positive, bolstered by technological advancements enhancing device usability and effectiveness. Innovations such as digital integration enabling AEDs to alert medical services and direct rescuers via GPS automatically are becoming increasingly feasible. Additionally, there is a push towards manufacturing cost reductions and developing environmentally tailored AED options to broaden usage scenarios. The ongoing research on improving diagnostic features and device customization illustrates a proactive approach to overcoming existing limitations, suggesting a promising trajectory for increased AED accessibility and effectiveness in emergency response, ultimately saving more lives.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.65 billion |
Estimated Year [2024] | USD 1.80 billion |
Forecast Year [2030] | USD 3.13 billion |
CAGR (%) | 9.59% |
Regional Insights
In the Americas, particularly in the United States and Canada, there is a high awareness of the importance of AEDs due to governmental policies and public health initiatives that promote AED training and accessibility. Many public places, such as schools, airports, and sports facilities, must have AEDs. This region shows a mature market with steady growth, driven by well-established healthcare infrastructure and stringent regulations that encourage the deployment of AEDs. The EMEA region presents a mixed but growing AED market landscape. In Europe, countries such as the UK, Germany, and France have strong market penetration due to robust health and safety regulations and increasing public awareness campaigns. The Middle East shows potential growth due to improving healthcare infrastructure and rising health awareness. Africa, however, has lower penetration and adoption rates due to economic constraints and less developed healthcare systems, yet the market is slowly growing as awareness and infrastructure improve. The APAC region is rapidly growing in terms of AED market penetration, driven by increasing healthcare expenditures and government initiatives to improve emergency medical response systems. Countries such as Japan, Australia, and South Korea have high adoption rates owing to solid regulatory frameworks and public health campaigns. Meanwhile, emerging economies such as China and India present significant growth opportunities due to increasing urbanization, rising middle-class populations, and improving healthcare awareness.
Market Insights
The market dynamics represent an ever-changing landscape of the Automated External Defibrillator Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Automated External Defibrillator Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Automated External Defibrillator Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Introduction of SCHILLER AG's FRED Easy G2, An Automated External Defibrillator
SCHILLER AG announced the launch of the FRED easy G2, an innovative automated external defibrillator that fulfilled CE certification standards per MDR regulations. Specifically designed to facilitate both basic and advanced life support, this versatile device is available in semi-automatic and fully automatic modes to cater to the varied expertise of users. The FRED easy G2 enhanced intervention efficiency with its compact and lightweight design, ensuring portability. [Published On: 2024-03-25]
Innovation in Emergency Medical Technologies as Stryker Launched LIFEPAK CR2 at Criticare 2024
At the Criticare National Conference in Kolkata, Stryker introduced LIFEPAK CR2, an Automated External Defibrillator. The LIFEPAK CR2 is designed to enhance the effectiveness of rescuers during sudden cardiac arrest by providing advanced CPR guidance and a rapid shock capability through its QUIK-STEP electrodes for swift deployment and an integrated Shock Advisory System that evaluates the need for defibrillation. This device also incorporated feedback mechanisms that adjust voice prompts based on real-time detection of CPR quality, ensuring optimal patient care during emergencies. [Published On: 2024-03-22]
Expansion of Safe Life AB in the U.S. Through Strategic Acquisitions of AED Authority and AED Market
Safe Life AB has significantly broadened its footprint in the United States' defibrillation sector by acquiring AED Authority and AED Market, following a successful integration with Coro Medical. These acquisitions enhanced Safe Life AB's portfolio, adding comprehensive AED program management through the AED Authority and extending accessibility of AEDs in public and private sectors via the AED Market. [Published On: 2023-11-13]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Automated External Defibrillator Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Automated External Defibrillator Market, highlighting leading vendors and their innovative profiles. These include AMI Italia S.r.l., BPL Medical Technologies Private Limited, CU Medical Systems, Inc., Fukuda Denshi Co.,Ltd., GE HealthCare Technologies Inc., GS Elektromedizinische Gerate G. Stemple GmbH, Koninklijke Philips N.V., Laerdal Medical AS, Mediana Co.,Ltd, Metrax GmbH, METsis Medikal, Nihon Kohden Corporation, OIARSO S COOP, Progetti Srl, Schiller AG, SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD., Stryker, Welch Allyn by Hillrom Company Inc., and ZOLL Medical Corporation by Asahi Kasei Corporation.
Market Segmentation & Coverage